#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15894	16S	1529	1529	99.93	16S.l15.c17.ctg.2	2395	803.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1717	1717	T	971	T,A	969,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15894	16S	1529	1529	99.93	16S.l15.c17.ctg.2	2395	803.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1451	1451	C	1059	C,A,T	1056,2,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27992	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4231	826.0	0	.	n	.	0	T695C	SNP	695	695	T	1269	1269	C	1075	C,T,A	1073,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27992	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4231	826.0	0	.	n	.	0	G1365A	SNP	1365	1365	G	1939	1939	A	1172	A,G	1169,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27992	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4231	826.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2545	2545	C	1023	C,T,A	1021,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27992	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4231	826.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2619	2619	A	926	A,T,C	924,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27992	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4231	826.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3171	3171	C	997	C,A	996,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2578	folP	855	855	100.0	folP.l15.c4.ctg.1	2035	158.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1232	1234	AGC	238;242;243	A,G;G,C;C,A	236,2;241,1;242,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5492	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3898	175.8	1	SNP	p	S91F	0	.	.	271	273	TCC	750	752	TCC	204;206;208	T;C,T;C	204;205,1;208	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5492	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3898	175.8	1	SNP	p	D95G	0	.	.	283	285	GAC	762	764	GAC	226;225;224	G;A,G;C	226;224,1;224	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5492	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3898	175.8	1	SNP	p	D95N	0	.	.	283	285	GAC	762	764	GAC	226;225;224	G;A,G;C	226;224,1;224	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	2168	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1925	140.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1230	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1443	106.0	0	.	n	.	0	A197.	DEL	197	197	A	782	782	A	233	A	233	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	27	5256	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3554	184.8	1	SNP	p	D86N	0	.	.	256	258	GAC	919	921	GAC	251;251;249	G;A;C,A	251;251;248,1	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	27	5256	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3554	184.8	1	SNP	p	S87I	0	.	.	259	261	AGT	922	924	AGT	249;246;247	A;G;T	249;246;247	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	27	5256	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3554	184.8	1	SNP	p	S87R	0	.	.	259	261	AGT	922	924	AGT	249;246;247	A;G;T	249;246;247	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	27	5256	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3554	184.8	1	SNP	p	S87W	0	.	.	259	261	AGT	922	924	AGT	249;246;247	A;G;T	249;246;247	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	27	5256	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3554	184.8	1	SNP	p	S88P	0	.	.	262	264	TCC	925	927	TCC	249;248;252	T,C;C,A;C,T	248,1;247,1;250,2	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4594	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3271	175.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1861	1863	GGC	266;264;261	G;G;C	266;264;261	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	4478	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	195.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1507	1509	GCA	271;273;271	G,A;C;A	270,1;273;271	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4478	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	195.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1510	1512	ATC	271;271;270	A;T;C	271;271;270	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4478	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	195.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1522	1524	GTG	258;262;264	G,A;T,C;G,T,C	257,1;261,1;262,1,1	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4478	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	195.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1522	1524	GTG	258;262;264	G,A;T,C;G,T,C	257,1;261,1;262,1,1	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4478	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	195.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2026	2028	ACC	239;237;240	A;C;C	239;237;240	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4478	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	195.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2080	2082	GCG	233;235;233	G;C;G,A	233;235;232,1	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4478	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	195.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2080	2082	GCG	233;235;233	G;C;G,A	233;235;232,1	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4478	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	195.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2203	2205	GGC	253;255;257	G;G,T;C	253;254,1;257	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4478	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	195.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2212	2214	GGC	260;259;260	G,T,A;G,T;C,G	258,1,1;258,1;259,1	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4478	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	195.8	1	SNP	p	P552S	1	.	.	1654	1656	TCG	2230	2232	TCG	252;251;244	T,G,A;C;G,C	249,2,1;251;243,1	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6024	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3621	207.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1916	1918	CCG	233;234;232	C;C;G	233;234;232	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2594	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2376	136.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	905	905	C	186	C	186	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3150	porB1b	1047	1047	98.76	porB1b.l6.c17.ctg.1	1855	209.8	1	SNP	p	G120K	1	G120K	NONSYN	358	360	GGC	811	813	AAG	293;295;294	A,C;A;G,C	292,1;295;293,1	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3150	porB1b	1047	1047	98.76	porB1b.l6.c17.ctg.1	1855	209.8	0	.	p	.	0	E212D	NONSYN	634	636	GAA	1087	1089	GAT	287;283;282	G;A;T	287;283;282	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3150	porB1b	1047	1047	98.76	porB1b.l6.c17.ctg.1	1855	209.8	0	.	p	.	0	H213G	NONSYN	637	639	CAT	1090	1092	GGT	282;281;278	G;G;T	282;281;278	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3150	porB1b	1047	1047	98.76	porB1b.l6.c17.ctg.1	1855	209.8	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1096	1098	GCT	281;279;283	G,C;C;T	280,1;279;283	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3150	porB1b	1047	1047	98.76	porB1b.l6.c17.ctg.1	1855	209.8	0	.	p	.	0	I218M	NONSYN	652	654	ATC	1105	1107	ATG	275;277;276	A;T;G	275;277;276	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3150	porB1b	1047	1047	98.76	porB1b.l6.c17.ctg.1	1855	209.8	0	.	p	.	0	R257T	NONSYN	769	771	AGG	1222	1224	ACG	239;236;234	A,T;C,A;G	238,1;234,2;234	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3150	porB1b	1047	1047	98.76	porB1b.l6.c17.ctg.1	1855	209.8	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1228	1230	GTT	238;237;234	G;T;T	238;237;234	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3150	porB1b	1047	1047	98.76	porB1b.l6.c17.ctg.1	1855	209.8	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1342	1344	AAC	250;253;254	A;A;C	250;253;254	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3150	porB1b	1047	1047	98.76	porB1b.l6.c17.ctg.1	1855	209.8	1	SNP	p	A121D	1	.	.	361	363	GAC	814	816	GAC	294;289;288	G;A;C,A	294;289;286,2	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3150	porB1b	1047	1047	98.76	porB1b.l6.c17.ctg.1	1855	209.8	1	SNP	p	D121N	0	.	.	361	363	GAC	814	816	GAC	294;289;288	G;A;C,A	294;289;286,2	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	10940	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5461	250.1	0	.	p	.	0	P562S	NONSYN	1684	1686	CCG	2345	2347	TCG	299;297;294	T;C,T;G,A,T,C	299;296,1;291,1,1,1	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	10940	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5461	250.1	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2318	2320	CAT	307;305;304	C;A,T;T	307;304,1;304	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1694	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1377	153.1	1	SNP	p	V57M	1	.	.	169	171	ATG	718	720	ATG	293;295;296	A;T,A;G,T	293;294,1;295,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
